Log in

KBL Merger Corp IV Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $12.20
50-Day Range
MA: $12.20
52-Week Range
Now: $12.20
Average Volume1,087 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Shell Companies
Current SymbolNASDAQ:KBLMU



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KBLMU News and Ratings via Email

Sign-up to receive the latest news and ratings for KBLMU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

KBL Merger Corp IV (NASDAQ:KBLMU) Frequently Asked Questions

How has KBL Merger Corp IV's stock been impacted by Coronavirus?

KBL Merger Corp IV's stock was trading at $10.57 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KBLMU stock has increased by 15.4% and is now trading at $12.20.
View which stocks have been most impacted by COVID-19

Who are some of KBL Merger Corp IV's key competitors?

Who are KBL Merger Corp IV's key executives?

KBL Merger Corp IV's management team includes the following people:
  • Dr. Marlene R. Krauss M.D., CEO & Director (Age 74)
  • Mr. Joseph A. Williamson, COO & Director (Age 67)
  • Dr. Jean-Pierre Garnier Ph.D., Scientific Advisor (Age 73)
  • Dr. Myron L. Weisfeldt M.D., Scientific Advisor
  • Dr. Phyllis I. Gardner, Scientific Advisor (Age 69)

When did KBL Merger Corp IV IPO?

(KBLMU) raised $100 million in an IPO on Friday, June 2nd 2017. The company issued 10,000,000 shares at a price of $10.00 per share. Ladenburg Thalmann acted as the underwriter for the IPO and B. Riley, FBR and I-Bankers Securities were co-managers.

What is KBL Merger Corp IV's stock symbol?

KBL Merger Corp IV trades on the NASDAQ under the ticker symbol "KBLMU."

How do I buy shares of KBL Merger Corp IV?

Shares of KBLMU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is KBL Merger Corp IV's stock price today?

One share of KBLMU stock can currently be purchased for approximately $12.20.

What is KBL Merger Corp IV's official website?

The official website for KBL Merger Corp IV is www.kblmerger.com.

How can I contact KBL Merger Corp IV?

KBL Merger Corp IV's mailing address is 150 W 56th St Apt 5901, NEW YORK, NY 10019-3847, United States. The company can be reached via phone at +1-212-3195555.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.